Education
About Us
Working with TipRanks
Follow Us
Bonus Biogroup (IL:BONS)
:BONS
BONS Stock Chart & Stats
Day’s Range― - ―
52-Week Range9.00 - 22.80
Previous CloseN/A
Volume3.65M
Average Volume (3M)914.22K
Market Cap
174.02M
Enterprise ValueN/A
Total Cash (Recent Filing)328.00K
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.95
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,167,925,300
10 Day Avg. Volume1,278,575
30 Day Avg. Volume914,215
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Bonus Biogroup News
PremiumCompany Announcements
Bonus Biogroup Gains FDA Approval for Crucial Phase III ARDS Drug Trial
PremiumCompany Announcements
Court Approves Bonus Biogroup’s Warrant Extension Request---
BONS FAQ
What was Bonus Biogroup ’s price range in the past 12 months?
Bonus Biogroup lowest stock price was 9.00 and its highest was 22.80 in the past 12 months.
What is Bonus Biogroup ’s market cap?
Bonus Biogroup ’s market cap is 174.02M.
When is Bonus Biogroup ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bonus Biogroup ’s earnings last quarter?
Bonus Biogroup released its earnings results on Aug 29, 2021. The company reported -1.6 earnings per share for the quarter, missing the consensus estimate of N/A by -1.6.
Is Bonus Biogroup overvalued?
According to Wall Street analysts Bonus Biogroup ’s price is currently Overvalued.
Does Bonus Biogroup pay dividends?
Bonus Biogroup does not currently pay dividends.
What is Bonus Biogroup ’s EPS estimate?
Bonus Biogroup ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bonus Biogroup have?
Bonus Biogroup has 1,167,925,300 shares outstanding.
What happened to Bonus Biogroup ’s price movement after its last earnings report?
Bonus Biogroup reported an EPS of -1.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Bonus Biogroup ?
Currently, no hedge funds are holding shares in IL:BONS
---
Company Description
Bonus Biogroup
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.
---
Technical Analysis
---